文献速递关节外科

全膝关节置换术中术中使用氯胺酮不能减少疼痛和阿片类药物消耗:一项前瞻性随机对照试验

Intraoperative Ketamine in Total Knee Arthroplasty Does Not Decrease Pain and Narcotic Consumption: A Prospective Randomized Controlled Trial.
PubMed 文献 · J Arthroplasty · 2019-04-12

这项前瞻性、随机、双盲临床试验纳入91例在脊髓麻醉下接受初次全膝关节置换术的患者,随机接受术中氯胺酮输注(6 mcg/kg/min持续75分钟)或生理盐水安慰剂。结果显示,除术后第1天和第4天平均疼痛及术后第4天最轻疼痛外,氯胺酮组与安慰剂组在各时间点疼痛评分及住院吗啡当量消耗均无差异。作者认为,作为多模式疼痛管理方案的一部分,术中使用氯胺酮未能在全膝关节置换术后带来具有临床意义的疼痛改善和阿片类药物消耗减少。

要点

  • 术中氯胺酮输注6 mcg/kg/min持续75分钟未减少全膝关节置换术后阿片类药物消耗。
  • 仅术后第1天和第4天平均疼痛评分及术后第4天最轻疼痛评分在氯胺酮组较低。
  • 作者认为术中使用氯胺酮未带来具有临床意义的疼痛改善。

核心结论

  • 作为多模式疼痛管理方案的一部分,术中使用氯胺酮未能在全膝关节置换术后带来具有临床意义的疼痛改善和阿片类药物消耗减少。

研究设计与样本

  • 前瞻性、随机、双盲临床试验,2017年至2018年单中心纳入91例在脊髓麻醉下接受初次全膝关节置换术的患者。
  • 患者随机接受术中氯胺酮输注6 mcg/kg/min持续75分钟或生理盐水安慰剂,所有患者均接受脊髓麻醉及相同的入路、疼痛管理和康复方案。

主要发现

  • 除术后第1天(45 vs 56,P=0.041)和第4天(39 vs 49,P=0.040)外,氯胺酮组与安慰剂组在各时间点平均疼痛评分无差异。
  • 最轻疼痛评分仅在术后第4天氯胺酮组低于安慰剂组(22 vs 35,P=0.011)。
  • 最大疼痛评分在所有时间点及住院吗啡当量消耗在两组间均无差异。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple studies have demonstrated that ketamine, a glutamate receptor blocker, may decrease postoperative pain in abdominal and orthopedic surgeries. However, its role with spinal anesthesia and total knee arthroplasty (TKA) remains unknown. The purpose of this study is to determine the efficacy of subanesthetic dosing of ketamine during TKA on postoperative pain and narcotic consumption. METHODS: In this prospective, randomized, double-blinded clinical trial, we enrolled 91 patients undergoing primary TKA with spinal anesthesia in a single institution from 2017 to 2018. Patients were randomized to receive intraoperative ketamine infusion at a rate of 6 mcg/kg/min for 75 minutes or a saline placebo. All patients received spinal anesthesia and otherwise identical surgical approaches, pain management, and rehabilitation protocols. Patient-reported visual analog pain scores were calculated preoperatively, postoperative days (POD) 0-7, and 2 weeks. Narcotic consumption was evaluated on POD 0 and 1. RESULTS: There was no difference in average pain between ketamine and placebo at all time points except for at PODs 1 (45 vs 56, P = .041) and 4 (39 vs 49, P = .040). For least pain experienced, patients administered with ketamine experienced a reduction in pain only at POD 4 (22 vs 35, P = .011). There was no difference in maximum pain cohorts at all time points of the study or in-hospital morphine equivalents between the 2 cohorts. CONCLUSION: As part of multimodal pain management protocol, intraoperative ketamine does not result in a clinically significant improvement in pain and narcotic consumption following TKA.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Tan TL, Longenecker AS, Rhee JH, et al. Intraoperative Ketamine in Total Knee Arthroplasty Does Not Decrease Pain and Narcotic Consumption: A Prospective Randomized Controlled Trial. J Arthroplasty. 2019. PMID: 31084971. doi:10.1016/j.arth.2019.04.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。